{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:21:56Z","timestamp":1791973316725,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Whole Body Low Dose CT (WBLDCT) has important advantages as a first-line imaging modality for bone disease assessment in patients with plasma cell disorders and has been included in the 2014 International Myeloma Working Group (IMWG) criteria for multiple myeloma (MM) definition. Nevertheless, standardization guidelines for the optimal use of WBLDCT in MM patients are still lacking, preventing its more widespread use, both in daily practice and clinical trials. The aim of this report by the Bone Group of the IMWG is to provide practical recommendations for the acquisition, interpretation and reporting of WBLDCT in patients with multiple myeloma and other plasma cell disorders.<\/jats:p>","DOI":"10.1038\/s41408-018-0124-1","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T10:40:00Z","timestamp":1538649600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group"],"prefix":"10.1038","volume":"8","author":[{"given":"Lia A.","family":"Moulopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Koutoulidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Hillengass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zamagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus D.","family":"Aquerreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lentzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus San","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios A.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G. M.","family":"Durie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Delorme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"key":"124_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/annonc\/mdi235","volume":"16","author":"E Terpos","year":"2005","unstructured":"Terpos, E. & Dimopoulos, M. A. Myeloma bone disease: pathophysiology and management. Ann. Oncol. 16, 1223\u20131231 (2005).","journal-title":"Ann. Oncol."},{"key":"124_CR2","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","volume":"31","author":"E Terpos","year":"2013","unstructured":"Terpos, E. et al. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J. Clin. Oncol. 31, 2347\u20132357 (2013).","journal-title":"J. Clin. Oncol."},{"key":"124_CR3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie, B. G. & Salmon, S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36, 842\u2013854 (1975).","journal-title":"Cancer"},{"key":"124_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bjh.14827","volume":"178","author":"A Chantry","year":"2017","unstructured":"Chantry, A. et al. Guidelines for the use of imaging in the management of patients with myeloma. Br. J. Haematol. 178, 380\u2013393 (2017).","journal-title":"Br. J. Haematol."},{"key":"124_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0009-9260(67)80010-2","volume":"18","author":"GA Edelstyn","year":"1967","unstructured":"Edelstyn, G. A., Gillespie, P. J. & Grebbell, F. S. The radiological demonstration of osseous metastases. Experimental observations. Clin. Radiol. 18, 158\u2013162 (1967).","journal-title":"Clin. Radiol."},{"key":"124_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working G.","year":"2003","unstructured":"International Myeloma Working G. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br. J. Haematol. 121, 749\u2013757 (2003).","journal-title":"Br. J. Haematol."},{"key":"124_CR7","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V. et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15, e538\u2013e548 (2014).","journal-title":"Lancet Oncol."},{"key":"124_CR8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1148\/radiol.13131529","volume":"271","author":"SL Giles","year":"2014","unstructured":"Giles, S. L. et al. Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. Radiology 271, 785\u2013794 (2014).","journal-title":"Radiology"},{"key":"124_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180562","volume":"12","author":"TJP Bray","year":"2017","unstructured":"Bray, T. J. P. et al. Diagnostic utility of whole body Dixon MRI in multiple myeloma: a multi-reader study. PLoS ONE 12, e0180562 (2017).","journal-title":"PLoS ONE"},{"key":"124_CR10","doi-asserted-by":"crossref","unstructured":"Koutoulidis, V., Papanikolaou, N., Moulopoulos, L. A. Functional and molecular MRI of the bone marrow in multiple myeloma. Br. J. Radiol. 91:20170389 (2018).","DOI":"10.1259\/bjr.20170389"},{"key":"124_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00256-008-0607-4","volume":"38","author":"TG Gleeson","year":"2009","unstructured":"Gleeson, T. G. et al. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skelet. Radiol. 38, 225\u2013236 (2009).","journal-title":"Skelet. Radiol."},{"key":"124_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00330-007-0738-3","volume":"18","author":"P Kropil","year":"2008","unstructured":"Kropil, P. et al. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma. Eur. Radiol. 18, 51\u201358 (2008).","journal-title":"Eur. Radiol."},{"key":"124_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/07357907.2013.764565","volume":"31","author":"K Princewill","year":"2013","unstructured":"Princewill, K., Kyere, S., Awan, O. & Mulligan, M. Multiple myeloma lesion detection with whole body CT versus radiographic skeletal survey. Cancer Invest. 31, 206\u2013211 (2013).","journal-title":"Cancer Invest."},{"key":"124_CR14","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.ejrad.2014.02.008","volume":"83","author":"MB Wolf","year":"2014","unstructured":"Wolf, M. B. et al. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease. Eur. J. Radiol. 83, 1222\u20131230 (2014).","journal-title":"Eur. J. Radiol."},{"key":"124_CR15","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3892\/ol.2017.5723","volume":"13","author":"L Lambert","year":"2017","unstructured":"Lambert, L. et al. Whole-body low-dose computed tomography in multiple myeloma staging: superior diagnostic performance in the detection of bone lesions, vertebral compression fractures, rib fractures and extraskeletal findings compared to radiography with similar radiation exposure. Oncol. Lett. 13, 2490\u20132494 (2017).","journal-title":"Oncol. Lett."},{"key":"124_CR16","volume":"7","author":"J Hillengass","year":"2017","unstructured":"Hillengass, J. et al. Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group. Blood. Cancer J. 7, e599 (2017).","journal-title":"Cancer J."},{"key":"124_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1148\/radiology.154.2.3966137","volume":"154","author":"JS Schreiman","year":"1985","unstructured":"Schreiman, J. S., McLeod, R. A., Kyle, R. A. & Beabout, J. W. Multiple myeloma: evaluation by CT. Radiology 154, 483\u2013486 (1985).","journal-title":"Radiology"},{"key":"124_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2214\/ajr.178.6.1781429","volume":"178","author":"AH Mahnken","year":"2002","unstructured":"Mahnken, A. H. et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. Am. J. Roentgenol. 178, 1429\u20131436 (2002).","journal-title":"Am. J. Roentgenol."},{"key":"124_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejrad.2004.04.015","volume":"54","author":"M Horger","year":"2005","unstructured":"Horger, M. et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur. J. Radiol. 54, 289\u2013297 (2005).","journal-title":"Eur. J. Radiol."},{"key":"124_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.carj.2010.01.003","volume":"61","author":"TG Gleeson","year":"2010","unstructured":"Gleeson, T. G. et al. Image quality in low-dose multidetector computed tomography: a pilot study to assess feasibility and dose optimization in whole-body bone imaging. Can. Assoc. Radiol. J. 61, 258\u2013264 (2010).","journal-title":"Can. Assoc. Radiol. J."},{"key":"124_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1148\/radiol.2015132766","volume":"276","author":"LL Geyer","year":"2015","unstructured":"Geyer, L. L. et al. State of the Art: Iterative CT Reconstruction Techniques. Radiology 276, 339\u2013357 (2015).","journal-title":"Radiology"},{"key":"124_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1259\/bjr\/21850180","volume":"81","author":"M Horger","year":"2008","unstructured":"Horger, M. et al. Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters. Br. J. Radiol. 81, 386\u2013396 (2008).","journal-title":"Br. J. Radiol."},{"key":"124_CR23","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.ejrad.2016.10.015","volume":"85","author":"C Schabel","year":"2016","unstructured":"Schabel, C. et al. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography. Eur. J. Radiol. 85, 2195\u20132199 (2016).","journal-title":"Eur. J. Radiol."},{"key":"124_CR24","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2214\/AJR.12.10037","volume":"203","author":"R Lamba","year":"2014","unstructured":"Lamba, R. et al. CT Hounsfield numbers of soft tissues on unenhanced abdominal CT scans: variability between two different manufacturers\u2019 MDCT scanners. Am. J. Roentgenol. 203, 1013\u20131020 (2014).","journal-title":"Am. J. Roentgenol."},{"key":"124_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1148\/radiol.2421052066","volume":"242","author":"BA Birnbaum","year":"2007","unstructured":"Birnbaum, B. A., Hindman, N., Lee, J. & Babb, J. S. Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology 242, 109\u2013119 (2007).","journal-title":"Radiology"},{"key":"124_CR26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2214\/AJR.07.2635","volume":"190","author":"A Baur-Melnyk","year":"2008","unstructured":"Baur-Melnyk, A. et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. Am. J. Roentgenol. 190, 1097\u20131104 (2008).","journal-title":"Am. J. Roentgenol."},{"key":"124_CR27","doi-asserted-by":"publisher","first-page":"20140185","DOI":"10.1259\/bjr.20140185","volume":"87","author":"A Surov","year":"2014","unstructured":"Surov, A., Bach, A. G., Tcherkes, A. & Schramm, D. Non-osseous incidental findings in low-dose whole-body CT in patients with multiple myeloma. Br. J. Radiol. 87, 20140185 (2014).","journal-title":"Br. J. Radiol."},{"key":"124_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2214\/AJR.12.10367","volume":"202","author":"M Schulze","year":"2014","unstructured":"Schulze, M. et al. Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study. AJR Am. J. Roentgenol. 202, 170\u2013179 (2014).","journal-title":"AJR Am. J. Roentgenol."},{"key":"124_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.acra.2011.09.016","volume":"19","author":"D Spira","year":"2012","unstructured":"Spira, D. et al. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)? Acad. Radiol. 19, 89\u201394 (2012).","journal-title":"Acad. Radiol."},{"key":"124_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.57","volume":"5","author":"Y Nishida","year":"2015","unstructured":"Nishida, Y. et al. Clinical and prognostic significance of bone marrow abnormalities in the appendicular skeleton detected by low-dose whole-body multidetector computed tomography in patients with multiple myeloma. Blood Cancer J. 5, e329 (2015).","journal-title":"Blood Cancer J."},{"issue":"Suppl 1","key":"124_CR31","first-page":"4404","volume":"130","author":"V Koutoulidis","year":"2017","unstructured":"Koutoulidis, V. et al. Diffuse medullary hyperdensities of the femora and humeri on whole-body low-dose computed tomography identify diffuse MRI pattern of involvement and correlate with advanced disease stage in patients with multiple myeloma. Blood 130(Suppl 1), 4404 (2017).","journal-title":"Blood"},{"key":"124_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1148\/radiology.194.1.7997579","volume":"194","author":"JD Laredo","year":"1995","unstructured":"Laredo, J. D. et al. Acute vertebral collapse: CT findings in benign and malignant nontraumatic cases. Radiology 194, 41\u201348 (1995).","journal-title":"Radiology"},{"key":"124_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00007632-199702010-00002","volume":"22","author":"H Taneichi","year":"1997","unstructured":"Taneichi, H., Kaneda, K., Takeda, N., Abumi, K. & Satoh, S. Risk factors and probability of vertebral body collapse in metastases of the thoracic and lumbar spine. Spine. 22, 239\u2013245 (1997).","journal-title":"Spine."},{"key":"124_CR34","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.ejrad.2015.07.024","volume":"84","author":"J Borggrefe","year":"2015","unstructured":"Borggrefe, J. et al. Association of osteolytic lesions, bone mineral loss and trabecular sclerosis with prevalent vertebral fractures in patients with multiple myeloma. Eur. J. Radiol. 84, 2269\u20132274 (2015).","journal-title":"Eur. J. Radiol."}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-018-0124-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-018-0124-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-018-0124-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:37:45Z","timestamp":1671518265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-018-0124-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1038\/s41408-018-0124-1","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,4]]},"assertion":[{"value":"13 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"95"}}